Clinical Trial Update: A Study of Nirogacestat in Japanese Adults With Desmoid Tumors/Aggressive Fibromatosis (DT/AF) [Phase 2]

View source ↗

Summary

This document provides an update on a Phase 2 clinical trial of nirogacestat in Japanese adults with desmoid tumors/aggressive fibromatosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Desmoid-type Fibromatosis

Drugs mentioned

• Nirogacestat (nirogacestat)

Snippet

Sponsor: SpringWorks Therapeutics, Inc. | Conditions: Desmoid Tumor, Aggressive Fibromatosis | Phase 2 | Status: ACTIVE_NOT_RECRUITING